uniQure (QURE) Return on Invested Capital (2016 - 2025)
uniQure's (QURE) quarterly Return on Invested Capital came in at 0.04% in Q2 2025, down 2.0% year-on-year from 0.04% in Q2 2024, and down 63.89% quarter-over-quarter from 0.02% in Q1 2025.
uniQure (QURE) Return on Invested Capital (2016 - 2025) Analysis & Trends
uniQure's Return on Invested Capital history runs 7 years deep, the most recent figure standing at 0.04% for Q2 2025.
- On a quarterly basis, Return on Invested Capital fell 2.0% year-over-year to 0.04% in Q2 2025; TTM through Jun 2025 was 0.04%, a 2.0% decrease from a year earlier, with the FY2023 full-year figure at 0.1%, changed N/A from the prior year.
- Return on Invested Capital slipped to 0.04% in Q2 2025 per QURE's latest filing, from 0.02% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.02% in Q3 2024 and bottomed at 0.11% in Q2 2022.
- The 4-year median for Return on Invested Capital is 0.02% (2025), against an average of 0.03%.
- Across the five-year window, Return on Invested Capital rose 9 bps in 2023 and decreased 2 bps in 2025, its largest moves.
- Year by year, Return on Invested Capital stood at 0.03% in 2022, then grew by 1 bps to 0.03% in 2023, then gained by 28 bps to 0.02% in 2024, then slumped by 110 bps to 0.04% in 2025.
- Per Business Quant, the three latest QURE Return on Invested Capital figures stand at 0.04% (Q2 2025), 0.02% (Q1 2025), and 0.02% (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,320.50 Bn | 66,320.21 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.93 Bn | 468.14 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 122.22 Bn | 114.98 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.96 Bn | 61.21 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.07 Bn | 50.89 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.60 Bn | 34.59 Bn | 959.66 Mn | - |
| 10 | uniQure | 2.43 Bn | 2.43 Bn | 3.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -0.04% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | -0.05% |
| Jun 30, 2022 | -0.11% |
| Dec 31, 2018 | -0.03% |
| Sep 30, 2018 | -0.05% |
| Jun 30, 2018 | -0.08% |
| Mar 31, 2018 | -0.09% |
| Dec 31, 2017 | -0.09% |
| Sep 30, 2017 | -0.08% |
| Dec 31, 2016 | -0.24% |